GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment.

Overview

authors

Vlachostergios, Panagiotis J
Balmiki, R L
Daya, R

publication date

July 2, 2015

published in

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Journal

Research

keywords

Bone Neoplasms
Osteogenesis
Peptides
Prostatic Neoplasms, Castration-Resistant

Identity

Scopus Document Identifier

84944515577

Digital Object Identifier (DOI)

10.1007/s12094-015-1324-9

PubMed ID

26133520

Additional Document Info

volume

17

issue

11